| Pvmg, Primary Care, Sterling | |
|
620 Iris Dr Sterling CO 80751-4716 | |
| (970) 522-7266 | |
| Not Available |
| Full Name | Pvmg, Primary Care, Sterling |
|---|---|
| Speciality | Internal Medicine |
| Location | 620 Iris Dr, Sterling, Colorado |
| Authorized Official Name and Position | Jana Conroy (MANAGER CREDENTIALING) |
| Authorized Official Contact | 9706244443 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Pvmg, Primary Care, Sterling 2695 Rocky Mountain Ave Ste 150 Loveland CO 80538-9071 Ph: (970) 522-7266 | Pvmg, Primary Care, Sterling 620 Iris Dr Sterling CO 80751-4716 Ph: (970) 522-7266 |
| NPI Number | 1104133073 |
|---|---|
| Provider Enumeration Date | 09/13/2010 |
| Last Update Date | 12/20/2019 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104133073 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
News Archive
An international team of scientists has identified a human molecule — biliverdin — as a potential severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) target. The binding of the heme metabolite to the N-terminal domain of SARS-CoV-2 is associated with the virus's ability to dodge the immune system by suppressing antibody binding to the spike protein.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced that it has entered into a non-exclusive product distribution agreement with Siemens Healthcare for the sale of its Calypso® System in Europe. Under terms of the agreement, Siemens retains non-exclusive rights to sell Calypso's real-time tracking technology to existing and prospective Siemens linear accelerator customers throughout Europe for a period of three years.
In order to make meaningful gains in cardiovascular disease care, primary care medical practices should adopt a set of care improvements specific to their practice size and type, according to a new study from the national primary care quality improvement initiative EvidenceNOW.
AnaptysBio, Inc., a privately-held therapeutic antibody platform and product company, today announced it has been awarded a contract by the Defense Advanced Research Projects Agency (DARPA), to use its proprietary somatic hypermutation (SHM) technology platform to generate novel high affinity thermally stable antibodies that could be used by the military in antibody-based biosensors, including those that can detect bioterrorist threats.
Engineers are to develop new imaging technology that could provide more accurate cancer treatments.
› Verified 7 days ago
Sterling Regional Medcenter Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 615 Fairhurst St, Sterling, CO 80751 Phone: 970-522-0122 Fax: 970-522-8532 | |
Ncmc Specialty Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1405 S 8th Ave, Ste 104, Sterling, CO 80751 Phone: 970-526-8181 | |
Blue Sage Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 615 Fairhurst St, Sterling, CO 80751 Phone: 970-522-0122 | |
High Country Internal Medicine, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 620 Iris Dr, Sterling, CO 80751 Phone: 970-522-7266 Fax: 970-522-4258 | |
Securemd Professionals - Colorado Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 110 S 3rd Ave, Sterling, CO 80751 Phone: 215-589-9001 Fax: 215-589-9030 | |
Second Ray: Health And Wellness Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 428 S 2nd St, Sterling, CO 80751 Phone: 406-212-4523 Fax: 402-337-8898 |